MEKanistic Arresting Cancer Resistance
  • Home
  • Science
  • Clinical Progress
  • Market
  • Pipeline
  • News
  • About
  • Contact

Terms & Conditions

Effective Date: April 3, 2026 | Last Updated: April 3, 2026

Back to Home

1. Agreement to Terms

Welcome to MEKanistic Therapeutics ("MEKanistic," "Company," "we," "us," or "our"). These Terms and Conditions ("Terms") govern your access to and use of the MEKanistic website at www.mekanistic.com (the "Site").

By accessing or using the Site, you agree to be bound by these Terms and our Privacy Policy. If you do not agree with these Terms, you must not access or use the Site.

We reserve the right to modify these Terms at any time. Changes will be effective upon posting to the Site. Your continued use of the Site after any changes constitutes acceptance of the revised Terms.

Important Medical Disclaimer

The information on this Site is for informational purposes only and is NOT intended to:

  • Provide medical advice, diagnosis, or treatment
  • Replace consultation with a qualified healthcare professional
  • Serve as a recommendation for any specific tests, treatments, or procedures
  • Create a doctor-patient relationship

ALWAYS seek the advice of your physician or other qualified health provider with any questions regarding a medical condition. NEVER disregard professional medical advice or delay seeking it because of information you read on this Site.

2. Investigational Drug Disclaimer

MEKanistic Therapeutics is a clinical-stage biotechnology company developing investigational cancer therapies. Our lead compound, MTX-531, and all other compounds in our pipeline are investigational drugs that have not been approved by the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), or any other regulatory authority.

2.1 No FDA Approval

MTX-531 and other MEKanistic compounds have not been proven to be safe or effective for the treatment of any disease or medical condition. They are available only through approved clinical trials conducted under Investigational New Drug (IND) applications.

2.2 Clinical Trial Information

Information about clinical trials on this Site is provided for informational purposes only. Participation in a clinical trial:

  • Does not guarantee access to the investigational drug
  • Does not guarantee any therapeutic benefit
  • May involve unknown risks and side effects
  • Requires meeting specific eligibility criteria
  • Is subject to informed consent and regulatory oversight

If you are interested in participating in a clinical trial, please consult with your healthcare provider and contact the appropriate clinical trial site.

2.3 Preclinical and Clinical Data

Any preclinical (animal or laboratory) and clinical data presented on this Site are based on research studies and should not be interpreted as evidence of safety or efficacy in humans. Past results do not guarantee future outcomes. Individual results may vary.

3. Forward-Looking Statements

This Site contains forward-looking statements regarding:

  • Clinical trial timelines and anticipated enrollment dates
  • Regulatory submissions (IND, NDA, BLA filings)
  • Future development plans and strategic initiatives
  • Market opportunities and addressable patient populations
  • Potential therapeutic benefits and competitive positioning

These forward-looking statements are subject to significant risks, uncertainties, and assumptions, including but not limited to:

  • Regulatory approval requirements and delays
  • Clinical trial outcomes and patient enrollment challenges
  • Manufacturing, supply chain, and funding availability
  • Competitive developments and intellectual property disputes
  • Changes in healthcare policy, reimbursement, and market conditions

Actual results may differ materially from those expressed or implied in forward-looking statements. MEKanistic undertakes no obligation to update or revise any forward-looking statements, except as required by law.

4. Permitted Use of the Site

4.1 Personal and Informational Use

This Site is intended for:

  • Healthcare professionals seeking information about MEKanistic's research and development programs
  • Patients and caregivers interested in learning about investigational therapies and clinical trials
  • Investors, partners, and media inquiring about the company
  • General public seeking educational information about cancer research

4.2 Prohibited Uses

You agree NOT to:

  • Use the Site for any unlawful purpose or in violation of these Terms
  • Reproduce, distribute, or create derivative works from Site content without written permission
  • Use automated systems (bots, scrapers, crawlers) to access or collect data from the Site
  • Attempt to gain unauthorized access to the Site, servers, or networks
  • Transmit viruses, malware, or other harmful code
  • Interfere with or disrupt the Site's operation or security
  • Impersonate MEKanistic, its employees, or representatives
  • Use the Site to promote competing products or services
  • Harvest or collect personal information about other users

5. Intellectual Property Rights

5.1 Ownership

All content on this Site, including but not limited to text, graphics, logos, images, videos, data, and software, is the property of MEKanistic Therapeutics or its licensors and is protected by U.S. and international copyright, trademark, patent, and other intellectual property laws.

5.2 Trademarks

The MEKanistic name, logo, "Arresting Cancer Resistance" tagline, "MTX-531," and other marks displayed on the Site are trademarks or service marks of MEKanistic Therapeutics. You may not use these marks without our prior written consent.

5.3 Limited License

We grant you a limited, non-exclusive, non-transferable, revocable license to access and use the Site for personal, non-commercial purposes in accordance with these Terms. This license does not include any right to:

  • Resell or make commercial use of the Site or its content
  • Download (other than page caching) or modify the Site or any portion thereof
  • Use data mining, robots, or similar data gathering tools
  • Remove or alter any copyright, trademark, or proprietary notices

6. Third-Party Links and Content

The Site may contain links to third-party websites, including:

  • Scientific publications (e.g., Nature Cancer, PubMed)
  • Clinical trial registries (e.g., ClinicalTrials.gov)
  • Partner institutions and collaborators
  • Social media platforms (LinkedIn, Twitter)

These links are provided for your convenience. MEKanistic does not endorse, control, or assume responsibility for the content, privacy policies, or practices of any third-party sites. Your use of third-party sites is at your own risk and subject to their respective terms and conditions.

7. User-Submitted Content

If you submit content to us through contact forms, email, or other means (including inquiries about clinical trials or partnership opportunities), you grant MEKanistic a non-exclusive, royalty-free, perpetual, worldwide license to use, reproduce, and disclose such content for business purposes, including:

  • Responding to your inquiries
  • Evaluating potential collaborations or clinical trial eligibility
  • Improving our products and services
  • Complying with legal and regulatory requirements

You represent and warrant that any content you submit:

  • Is accurate and complete to the best of your knowledge
  • Does not violate any third-party rights (including privacy rights)
  • Does not contain confidential or proprietary information you are not authorized to disclose

8. Privacy and Data Protection

Your privacy is important to us. Our collection, use, and protection of your personal information is governed by our Privacy Policy, which is incorporated into these Terms by reference.

By using the Site, you consent to the collection and use of your information as described in the Privacy Policy, including compliance with applicable data protection laws such as GDPR (for EU residents), CCPA (for California residents), and HIPAA (for health information).

9. Disclaimer of Warranties

THE SITE AND ALL CONTENT ARE PROVIDED "AS IS" AND "AS AVAILABLE" WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO:

  • Warranties of merchantability, fitness for a particular purpose, and non-infringement
  • Warranties regarding accuracy, reliability, or completeness of content
  • Warranties that the Site will be uninterrupted, secure, or error-free
  • Warranties that defects will be corrected

MEKanistic makes no representations or warranties about the suitability, reliability, or accuracy of information on the Site. Use of the Site is at your sole risk.

10. Limitation of Liability

TO THE FULLEST EXTENT PERMITTED BY LAW, MEKANISTIC THERAPEUTICS, ITS OFFICERS, DIRECTORS, EMPLOYEES, AGENTS, AND AFFILIATES SHALL NOT BE LIABLE FOR ANY:

  • Indirect, incidental, consequential, special, or punitive damages
  • Loss of profits, revenue, data, or business opportunities
  • Personal injury or property damage arising from your use of the Site
  • Unauthorized access to or alteration of your transmissions or data
  • Statements or conduct of any third party on or through the Site

IN NO EVENT SHALL MEKANISTIC'S TOTAL LIABILITY TO YOU EXCEED $100 USD OR THE AMOUNT YOU PAID TO ACCESS THE SITE (IF ANY), WHICHEVER IS LESS.

Some jurisdictions do not allow the exclusion or limitation of certain warranties or liabilities. In such jurisdictions, our liability will be limited to the maximum extent permitted by law.

11. Indemnification

You agree to indemnify, defend, and hold harmless MEKanistic Therapeutics, its officers, directors, employees, agents, and affiliates from and against any and all claims, liabilities, damages, losses, costs, and expenses (including reasonable attorneys' fees) arising out of or related to:

  • Your use or misuse of the Site
  • Your violation of these Terms
  • Your violation of any third-party rights, including intellectual property or privacy rights
  • Any content you submit to the Site

12. Governing Law and Dispute Resolution

12.1 Governing Law

These Terms shall be governed by and construed in accordance with the laws of the State of Minnesota, United States, without regard to its conflict of law principles.

12.2 Jurisdiction and Venue

Any legal action or proceeding arising out of or related to these Terms or the Site shall be brought exclusively in the state or federal courts located in Hennepin County, Minnesota. You consent to the personal jurisdiction of such courts and waive any objection to venue.

12.3 Arbitration (Optional)

Upon mutual agreement, disputes may be resolved through binding arbitration in accordance with the Commercial Arbitration Rules of the American Arbitration Association. The arbitration shall take place in Minneapolis, Minnesota.

13. Termination

MEKanistic reserves the right to terminate or suspend your access to the Site, without prior notice or liability, for any reason, including but not limited to:

  • Violation of these Terms
  • Fraudulent, abusive, or illegal activity
  • Request by law enforcement or regulatory authorities
  • Discontinuation of the Site or any portion thereof

Upon termination, your right to use the Site will immediately cease. Sections of these Terms that by their nature should survive termination (including disclaimers, limitations of liability, indemnification, and governing law) shall survive.

14. Severability and Waiver

14.1 Severability

If any provision of these Terms is found to be invalid, illegal, or unenforceable, the remaining provisions shall continue in full force and effect. The invalid provision shall be reformed to the extent necessary to make it valid and enforceable while preserving its intent.

14.2 Waiver

No waiver of any provision of these Terms shall be deemed a further or continuing waiver of that provision or any other provision. MEKanistic's failure to enforce any right or provision shall not constitute a waiver of that right or provision.

15. Entire Agreement

These Terms, together with our Privacy Policy, constitute the entire agreement between you and MEKanistic Therapeutics regarding the use of the Site and supersede all prior or contemporaneous communications, whether oral or written.

16. Contact Information

Questions About These Terms?

If you have any questions or concerns about these Terms & Conditions, please contact us:

MEKanistic Therapeutics

Legal Department

Email: legal@mekanistic.com

Phone: 612-200-3080

Address: Minneapolis, Minnesota, United States

For general inquiries:
Email: info@mekanistic.com

For media inquiries:
Adam Becker, MEKanistic
Email: adambecker@mekanistic.com

MEKanistic Arresting Cancer Resistance

Company

  • About Us
  • News
  • Contact
  • Privacy Policy
  • Terms & Conditions

Science

  • Our Technology
  • Pipeline
  • Clinical Progress
  • Market Opportunity

Resources

  • Publications
  • Press Releases

© 2026 MEKanistic Therapeutics. All rights reserved.